Publication | Open Access
Efficacy and Safety of Intranasal Peptide YY3–36 for Weight Reduction in Obese Adults
160
Citations
34
References
2007
Year
Intranasal PYY(3-36) as administered at these intervention doses and preprandial timing is not efficacious in inducing weight loss in obese patients after 12 wk of treatment.
| Year | Citations | |
|---|---|---|
2002 | 2.3K | |
2003 | 1.6K | |
2002 | 1.3K | |
1985 | 1.1K | |
2005 | 978 | |
1980 | 655 | |
2005 | 541 | |
2002 | 429 | |
2005 | 419 | |
2005 | 419 |
Page 1
Page 1